NEW YORK and LONDON, March 8, 2022 – Akari Therapeutics, Plc (Nasdaq: AKTX) (“Akari” or the “Company”), a biopharmaceutical company focused on innovative …
[Read more...] about Akari Therapeutics, Plc Announces $9.0 Million Registered Direct Offering